tissue differentiation; thus, Drosophila studies give us useful clues to investigate the complex mechanisms of mammalian development. For example, new insights into the molecular nature of mammalian development have emerged from analyses of the Pax gene family, mouse genes related to Drosophila paired box genes (Kessel and Gruss 19901. Pax genes are expressed with a distinct spatiotemporal pattern and are involved in several mouse and human genetic diseases (Gruss and Walther 19921. undulated, a mutation affecting the development of the mouse skeleton, is caused by a single amino acid change in the paired box of Paxl IBalling et al. 1988} .
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Another striking example concems MASH1, a rat factor homologous to the Drosophila achaete-scute complex (AS-C), that is specifically expressed in neuronal precursors {Johnson et al. 1990; Lo et al. 1991) . In Drosophila, AS-C is essential at the level of neuronal precursor formation ; thus, MASH1 is suggested to be involved in mammalian neural development.
Here, to analyze novel HLH proteins responsible for mammalian development including neural differentiation, we attempted cDNA cloning of rat factors by the polymerase chain reaction (PCR) using primers corresponding to the conserved amino acid sequences in the HLH regions of the Drosophila hairy (h) and Enhancer of split [E(spl) ] proteins. The Drosophila h gene, one of the pair-rule segmentation genes, is required at two different developmental stages: at the formation of alternate embryonic segments in early development and at normal neurogenesis in late development {Ingham et al. 1985; Rushlow et al. 1989 ; Jan and Jan 19901 . It has been suggested that the late h function involves suppression of the achaete [ac)gene of the AS-C, thus controlling the number of sensory organs (Botas et al. 1982; Villares and Cabrera 1987; Skeath and Carroll 1991) . The h protein has a basic HLH (B-HLH) domain (Rushlow et al. 1989) , which is necessary for DNA binding and dimerization [Murre et al. 1989; Davis et al. 1990} . In the B-HLH do-HES |amily, novel mammalian HLH factors main, h shows a high homology to m5, m7, and m8 of E(spl), neurogenic genes (Kl~'nbt et al. 1989; CamposOrtega and Knust 1990) .
In this study we show the molecular cloning and characterization of two novel rat HLH factors, designated HES-1 and HES-3. We describe their spatial and temporal expression patterns focusing on late embryonic and postnatal development, and characterize their transcriptional functions. Furthermore, we show that HES-1 inhibits the myogenic conversion of C3H10T1/2 (10T1/2) cells induced by MyoD.
Results

Isolation of novel HLH [actors by PCR
To isolate novel HLH factors expressed in the mammalian nervous system, we amplified cDNAs from rat whole embryos and adult nervous tissues by PCR using degenerate oligonucleotide primers (Lee et al. 1988; Saiki et al. 1988) . The primers were designed on the basis of the consensus sequence of the B-HLH domains of the We isolated four closely related but distinct clones and named the deduced amino acid sequences HES-1, HES-2, HES-3, and HES-4, according to their sequence homologies to the h and E(spl) gene products. The HES-3 clone was obtained from adult brain eDNA, and the other clones were isolated from embryo eDNA. HES-1 had the highest homology to the Drosophila h protein throughout the amplified region, whereas the other three showed high homology only in the helix regions and much lower homology in the loop region (Fig. 1 ). All four clones showed higher sequence homology to h than to E(spl), with the overall homologies of HES-1, HES-2, HES-3, and HES-4 to h in the amplified regions being 81%, 59%, 51%, and 46%, respectively. We chose two factors, HES-1 and HES-3, for further analysis and obtained their full-length eDNA clones.
Drosophila h and E(spl)
proteins
Structural analyses of HES-1 and HES-3
HES-1 cDNA encoded a protein of 281 amino acid resi- , h, and E(spl) proteins are depicted by bold letters, and the identical residues between HES-1 and h are connected by vertical bars. Percent (%} identity to h is shown at right.
HES
dues, and the calculated molecular mass was 29.6 kD {Fig. 2A). This protein showed 77% homology to the h gene product in the putative B-HLH domain (amino acid residues 33-92) and 43% homology in the downstream region (93--146) (boxed residues m Fig. 3A ). Another feature, the proline residue, present m the basic region of h and E(spl) was also conserved in the corresponding position of HES-1 (amino acid residue 40) (indicated by the asterisk in Fig. 3B ). HES-3 cDNA encoded a protein of 175 amino acid residues, and the calculated molecular mass was 19.1 kD {Fig. 2B}. The HES-3 protein showed -50% homology to the h gene product m the B-HLH domain. The first methionine codon was present at nucleotide 1; thus, this protein lacked the amino-terminal half of the basic region (see also Fig. 3A ). To avoid cloning artifacts, we investigated the sequences of three more independent cDNA clones of HES-3, but all had an m-frame stop codon 246 nucleotides upstream of this methionine (Fig.  2B ). Sequence examination of the region between the stop and methionine codons indicated that there was only one possible non-AUG initiation sequence, AUU, at 207 nucleotides upstream of the methionine codon. An AUU sequence was recently identified in TEF-1 mRNA as a major initiation codon (Xiao et al. 1991) . The in vitro translation analysis, however, indicated that protein synthesis started from AUG and not from AUU (data not shown). This AUG was therefore assigned as an initiation codon, although the possibility that the translation starts from AUU in vivo remains to be examined.
The two HES proteins shared 56% homology with each other in the B-HLH domain. In addition, within the two putative helices of HES-1 and HES-3 many residues were conserved, including the ones believed to confer HLH domains ( Fig. 3B ; Benezra et al. 1990 ). We also found that the sequence WRPW, or a similar one, was conserved in the carboxy-terminal regions of HES-1, HES-3, h, E(spl), and runt, another Drosophila pair-rule gene product (Fig. 3C) (Kania et al. 1990 ). Between the B-HLH domain and the carboxy-terminal region, the two HES proteins had a proline-rich portion (amino acid residues 156-247 of HES-1 and 108-167 of HES-3), whereas the h protein had a glutamine-rich part (149-261) (Fig.  3D ). Proline-rich and glutamine-rich regions are often found in transcription factors such as CTF/NF1 and Spl (Courey and Tjian 1988; Mermod et al. 1989) . Another feature involves a serine/threonine-rich region present in HES-1 (248-275) and h (262-298) but not in HES-3.
Spatial and temporal distribution of HES-1 mRNA
To analyze the tissue distribution and the ontogenetic expression pattem, we performed Northern blot experiments. As shown in Figure 4A , we detected a 1.7-kb HES-1 transcript in the embryos of days 13.5 and 17 {E13.5 and E17; lanes 1, 2), as well as in such adult tissues as the brain (lanes 3--5) and the liver (lane 7). Nerve growth factor (NGF}-treated PC12 cells, which resemble sympathetic neurons (Greene and Tischler 1976) , also produced HES-1 mRNA {lane 6). The HES-1 transcript Thr  ATG CCA GCT GAT ATA ATG GAG AAA AAT TCC TCG TCC CCG GTG GCT GCT ACC CCA GCC AGT GTC AAC ACG ACA CCG GAC AAA CCA AAG 175 (Gilbert 1991). In contrast, only low and relatively homogeneous expressions of HES-1 mRNA were detected in the other parts of the embryonal brain such as the mantle layer (Fig. 5D ) and the adult brain and spinal cord {data not shown). We also detected high levels of HES-1 mRNA in the epithelial cells of peripheral tissues such as the esophagus and the trachea (Fig. 5E, G) . The expression of HES-1 did not seem to correlate merely with cell proliferation. For example, the proliferating neuroblasts in the external granular layer of the neonatal cerebellum produced the transcript only at a background level (data not shown).
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In summary, HES-1 mRNA was detected in all tissues examined but was not homogeneous in detail. The expression was enriched in epithelial cells and in such mesoderm-derived cells as embryonal muscle cells. Furthermore, the expression was developmentally controlled in a tissue-specific manner.
Spatial and temporal distribution of HES-3 mRNA
In contrast to the wide distribution of HES-1 mRNA, a 1.9-kb HES-3 transcript was detected only in the adult brain (Fig. 6A, lanes 3,4) but not in the embryos, NGFtreated PC12 cells, or the liver (lanes 1,2,6,7) . In the brain, the cerebellum seemed to be the only place to express HES-3 mRNA; the other brain regions did not produce a detectable amount of the transcript (lanes 4,5). This specific expression was analyzed further by RNase protection assays (Fig. 6B) . Consistent with the above findings, neither the peripheral tissues nor the spinal cord of adults (lanes 4--12) produced HES-3 mRNA. Furthermore, various brain regions failed to produce HES-3 mRNA (lanes 14,16-18), whereas the cerebellum expressed a significant level of the transcript (lane 15). These results strongly suggest that HES-3 expression occurs only in the cerebellum. None of the nervous or peripheral tissues of embryos (El 8) produced HES-3 mRNA (data not shown). Ontogenetic analysis indicated that HES-3 mRNA was undetectable until postnatal day 6 (lane 19). However, the transcript appeared at a low level on the fourteenth day and exhibited a significant increase at the seventh week (lanes 20,21), in marked contrast with HES-1 mRNA, whose level was relatively unchanged during these periods (cf. Fig. 4B, lanes 19-21}. To determine the cell type expressing HES-3 mRNA, we performed in situ hybridization analyses. A high level of HES-3 transcript was detected specifically in the Purkinje cell layer of the adult cerebellum (Fig. 7A) . This layer contains Purkinje cells, large arborized neurons receiving >100,000 synapses and providing the only known output from the cerebellum. The higher magni- fication analysis clearly demonstrated that HES-3 gene was predominantly transcribed in Purkinje cells (Fig.  7C) . No positive signals were detected in any other parts of the brain, the retina, or the embryo sections of E14.5 and El8 (data not shown). Thus, HES-3 gave the striking observation of a neuron type-specific transcription factor in the m a m m a l i a n CNS. Consistent with RNase protection assays, no apparent signals were detected until postnatal day 5, but significant signals were detected in maturating Purkinje cells on postnatal day 11 (data not shown), thus suggesting that the appearance of HES-3 m R N A coincides with the terminal differentiation of these cells (Ito 1984) .
DNA-binding analysis of HES-1
To characterize the functions of the HES factors, we first assessed DNA-binding activity. The HES-1 protein was expressed in Escherichia coli and subjected to DNase I footprinting analysis. Although HLH factors such as MyoD have been shown to recognize the consensus sequence C A N N T G {called the E box; Blackwell and Weintraub 1990) , the introduction of a proline into the basic region of MyoD results in the loss of DNA-binding activity {Davis et al. 1990}. However, a recent study shows that E(spl) proteins, each of which contains a proline in its basic region (see Fig. 3B ), bind to a different sequence, CACNAG {called the N box), present in a cluster in the 5' regulatory regions of E(spl) genes themselves (K1/imbt et al. 1989; Tietze et al. 1992; N. Oellers and E. Knust, pers. comm.) . Therefore, we first tested whether HES-1, which also has a proline in the basic region, binds to the N-box sequence. As shown in Figure 8A , HES-1 clearly bound to the N-box regions (lane 3). Both CA-CAAG and CACGAG sequences were well protected by HES-1. The mutation analysis showed that the sequence CAC(A/G)AG was recognized most efficiently by HES- l (Fig. 8B, lane 1 ) . The mutation in the first, second, third, or sixth nucleotide of the CACNAG sequence totally abolished HES-1 binding [lanes 2,3,4, and 8, respectively}. The fourth position preferred A and G to T and C for HES-1 binding {lanes 5, 6). When the fifth nucleotide, A, was changed to T {thus conforming to the E box), a weak band {approximately one-eighth of the wild type) was observed {lane 7). Consistent with this result, only when an excess amount of HES-1 protein was used in the DNase I footprinting analysis could a slight difference in intensities be observed in several bands of the E-box regions {Fig. 8C, lane 2). We also tested several other E boxes such as the one in the muscle creatine kinase (MCK) enhancer but failed to detect effective HES-1 binding (see also Fig. 10B , lane 6, below). These results indicated that HES-1 bound more preferentially to the N box than to the E box. On the other hand, E47, an HLH factor without a proline in the basic region, bound efficiently to the E box, but not to the N box {Fig. 8B, lanes 10,16). Because the mutant MyoD containing a proline in the basic region inhibits the DNA-binding ability of other HLH factors, we then analyzed whether HES-1 attenuates the DNA-binding activity of other HLH factors. E47/E12 {Pan 1/Pan 21, two species produced from the E2A gene by alternative splicing, are well-characterized HLH factors. They are ubiquitously expressed in all cell types and bind to E-box sequences such as the KE2 site and the insulin enhancer (Murre et al. 1989; Nelson et al. 1990 ). As shown in Figure 8C , E. coli-expressed E47 clearly protected the KE2 sequence in the DNase I footprinting analysis {lane 4). The addition of an equimolar amount of HES-1, however, resulted in complete inhibition of the DNA-binding activity of E47. We then ana- lyzed whether HES-1 affects the DNA-binding activity of a different type of transcription factor. ATF-2, which has a leucine zipper motif but not an HLH domain, binds to the cAMP response element (CRE) (lane 7). The addition of an equimolar a m o u n t of HES-1 did not alter the DNAbinding ability of ATF-2 (lane 8). Furthermore, even a 10-fold molar excess of HES-1 caused no change in the ATF-2 activity (lane 9). Therefore, these data suggest that HES-1 specifically inhibits the DNA-binding activity of certain HLH factors.
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We also attempted to examine HES-3 expression in E.
coli to characterize its activity. However, for u n k n o w n reasons we failed to express HES-3 protein in E. coli.
Transcriptional analyses of HES-1 and HES-3
To chloramphenicol acetyltransferase (CAT) gene under the control of the J3-actin promoter linked to either six repeats of the N boxes (pN6-J3A-CAT) or seven repeats of the E boxes {pKE7-f~A-CAT). HES-1 significantly repressed CAT expression from the promoter containing the N boxes, whereas HES-3 and E47 did not affect CAT expression from the same promoter {Fig. 9A, lanes 1-4). HES-1 did not repress expression from the promoter containing the mutated N boxes (CA TNAG) that lost affinity for HES-1 (Fig. 9A,  lanes 5,6) . These results thus indicated that HES-1 acted as a transcriptional repressor by binding to the N box in this assay.
E47, on the other hand, activated CAT expression from the promoter containing the E boxes when compared with the basal level exhibited by the CAT plasmid 
18). (C) DNase I footprinting analysis was
carried out using the probes containing either the E boxes (KE2 sites)(lanes 1-5) or the CRE site (lanes 6-10). (Lanes 1, 3, 6) Control DNase digestion pattern with no protein added; (lanes 2, 4, 5) reaction with 2 ~.g of HES-1, 100 ng of E47, and both 100 ng of E47 and 200 ng of HES-1 (equimolar), respectively; (lanes 7-10) reaction with 250 ng of ATF2, both 250 ng of ATF2 and 200 ng of HES-1 (equimolar), both 250 ng of ATF2 and 2 ~g of HES-1 (10-fold molar excess), and 2 ~.g of HES-1, respectively. The regions protected by E47 and ATF2 axe bracketed at the right. alone ( Fig. 9B lanes 1,2) . However, when either HES-1 or HES-3 expression vector was cotransfected with the E47 plasmid, E47-induced CAT expression was totally abolished (E47 + HES-1 and E47 + HES-3). In the case of E47 + HES-1, CAT activity was even lower than the basal level, probably because HES-1 effectively antagonized the endogenous E12/E47 or equivalent HLH activators. HES-1, as well as HES-3 plasmids alone, also showed less CAT activity than the basal levels, probably for the same reason as noted above. These HLH factors had no effects on the control J3-actin promoter (data not shown). The results thus demonstrate that both HES-1 and HES-3 negatively regulate transcription.
HES-1 represses the functions of MyoD and MASH1
The above findings that HES genes encode transcription Cold Spring Harbor Laboratory Press on October 19, 2017 -Published by genesdev.cshlp.org Downloaded from , and HES-1 is also expressed in those cells {Figs. 4 and 5}. Therefore, we examined the effects of HES-1 on these factors.
As shown in Figure 10A , both MyoD and MASH 1 significantly activated transcription from the promoter containing the MCK enhancer Ilanes 4,81. Previous reports indicated that the MyoD/E47(E12) and MASH1/ E47(E12) complexes, rather than the MyoD and MASH1 homo-oligomers, are responsible for these trans-activations (Weintraub et al. 1991; Johnson et al. 1992) . In agreement with these reports, the addition of exogenous E47 further enhanced the trans-activations by MyoD and MASH1 {lanes 6,10}. However, the coexpression of HES-1 with these oligomers resulted in complete inhibition of transcriptional activation {lanes 5,7,9,11}. Neither HES-1 nor E47 alone affected the basal level of transcription {lanes 2,3). These results clearly demonstrated that HES-1 acts as a negative regulator of MyoD and MASH1.
Gel mobility-shift assays showed that MyoD/E47 and MASH1/E47 mixtures bound strongly to the MCK E-box sequence IFig. 10B, lanes 7,11}. However, the addition of HES-1 led to the inhibition of the DNA-binding activities of the MyoD/E47 and MASH1/E47 complexes {lanes 8,12). This negative regulation of HES-1 is probably the result of the deprivation of E47 from the complexes because HES-1 did not inhibit the DNA-binding activity of the MyoD homo-oligomer {lanes 2,3} but did inhibit that of E47 effectively (see Fig. 8C ). A weak band remained when HES-1 was added to the MyoD/E47 complex {lane 8}. This may be the result of either weak binding of the MyoD homo-oligomer or binding of the remnant MyoD/ E47 complex. MASH1 alone failed to bind to the MCK E box {lane 101, as reported previously {Johnson et al. 1992).
We then examined the effect of HES-1 on the myogenic conversion of 10T1/2 cells induced by MyoD. As shown in Figure 10C Itop}, MyoD effectively converted the cells into cells with muscle phenotypes [also see Table 1). Cotransfection of liES-1 expression plasmid, however, significantly decreased MyoD-induced myogenic conversion iFig. 10C, bottom~ Table 1 ), agreeing well with the above findings that HES-1 is a negative regulator of MyoD. Furthermore, the expression of HES-1 transcript was regulated in the course of myogenesis. HES-1 mRNA was expressed at a high level in the embryonal muscle while it was transcribed only at a low level in the adult muscle {Fig. 10D, lanes 1,2}. These results suggest that HES-1 may act as a negative regulator of myogenesis in vivo.
Discussion
Structure and distribution of the HES family
In this study we have described the molecular cloning and characterization of the lIES family, novel mammalian HLH factors. Both HES-1 and HES-3 have significant sequence homology in the B-HLH domain to Drosophila h and E(spl) proteins, as well as the conserved carboxyterminal sequence WRPW. These results suggest that the mammalian HES and Drosophila h and E(spl) genes originated from the same or closely related ancestral genes.
HES-1 and HES-3 genes show contrasting expression patterns: wide distribution in the former and Purkinje cell-specific expression in the latter. In the embryonal Table 1) were immunostained with anti-myoglobin antisera. Positive cells were very rare. (D) Northern blot analysis with HES-1 probe. Total RNAs (20 ~g) from the rat muscle of E18 (lanes 1, 3) or adult (lanes 2, 4) were analyzed. Lanes 3 and 4 show the ethidium bromide staining of the agarose gel corresponding to lanes 1 and 2, respectively. CNS, HES-1 is expressed at a high level by the neural progenitor cells present in the ependymal zone, but it decreases rapidly as neural differentiation proceeds. In the Drosophila eye, h is once expressed in undifferentiated cells as the morphogenetic furrow approaches, but it is lost before neural differentiation is manifest (Carroll and White 1989) . Thus, the time course of HES-1 expression regarding neural differentiation is somewhat similar to that of h. However, while the Drosophila h gene is not expressed by committed neural precursor cells or neurons, HES-1 m R N A is still present in those cells, although only at a low level. Thus, the expression pattern of HES-1 seems different from that of h in the differentiated nervous system.
In peripheral tissues, HES-1 is preferentially transcribed in the epithelial cells of the respiratory and gastrointestinal tracts and in embryonal mesoderm-derived tissues such as the muscle. During late embryogenesis,
Drosophila h is transiently expressed in various regions
including the tracheal pit, some parts of the gut, and the mesoderm {Carroll Carroll and Whyte 1989; Hooper et al. 1989) . Thus, the expression pattern of HES-1 m the peripheral tissues seems, at least in part, similar to that of the Drosophila h gene, although simple
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Cold al0T1/2 cells on 5-cm~b dishes were transfected with the MyoD expression vector (1 ~g in 3-5) and/or the HES-1 expression vector (3 ~g in 2 and 5; 1 ~g in 4). pCDM8-[3-gal (0.5 ~g) was cotransfected onto each plate to evaluate transfection efficiency. The amount of plasmid DNA was adjusted to 5 ~g with the control expression vector. bThe numbers of positive cells that were stained with anti-myoglobin immunoreactivity or ~-galactosidase activity were counted in 5-cm6 dishes. In the case of ~-galactosidase staining, when J3-gal( + 1 cells were found in doublets owing to proliferation, they were counted as one transfected cell to avoid overestimation of transfection efficiency. CThe majority of 13-gal(+) cells transfected with the MyoD plasmid was longer and larger than background 10T1/2 cells and did not seem to proliferate. They often had multiple nuclei and overlay the background cells. These characteristics were the same as those found in myoglobin( + ) cells transfected with MyoD plasmid (Fig. 10C) . In contrast, the [3-gal( + } cells transfected with MyoD + HES-1 (1 : 3) or control plasmid were morphologically indistinguishable from background cells and many of them were proliferating.
comparison is difficult because the anatomical structures and developmental processes are so different between invertebrates and vertebrates.
In contrast to HES-1, HES-3 substantially diverges from h in its structure as well as in its expression pattern. HES-3 is not expressed in any of the embryonal tissues tested but appears in cerebellar Purkinje cells between postnatal days 6 and 11. In the rat, Purkinje cells originate between days El4 and El7 and then migrate and align in a monolayer during the first 4 days after birth. The postnatal growth and synaptic maturation of Purkinje cells continue during the first month (Ito 1984) . Thus, the HES-3 expression pattern, with its lack of expression in the embryo and its postnatal sharp increase, suggests that HES-3 may be involved in the maturation and functional maintenance of Purkinje cells rather than their fate determination.
Transcriptional repression by HES factors
In transient cotransfection assays, we have shown that both HES-1 and HES-3 are negative regulators of transcription. HES-1 represses transcription by acting on two types of sequences, the E box and the N box, whereas HES-3 seems to act only on the E box.
HES-3 has no effects by itself on either the N box or the E box, and this inability is probably the result of the deletion of the amino-terminal half of the basic region. In this sense, HES-3 is similar to Id and HLH462, both of which lack the basic region. These two HLH negative regulators do not bind to the DNA template by themselves but inhibit other activators from binding by forming nonfunctional heterodimers (Benezra et al. 1990; Christy et al. 1991) . Thus, because HES-3 has an intact HLH domain, transcriptional repression by HES-3 is probably mediated through formation of a nonfunctional heterodimer with HLH activators.
In contrast, because HES-1 binds directly to the N box, its repressor activity seems unique compared with that of Id, HLH462, and HES-3. The mechanism of how HES-1 represses transcription through the N box is an intriguing problem. Competition for the N box between HES-1 and N box-binding activators is probably unlikely because N box-dependent transcriptional activation was not detected in NIH-3T3 cells (Fig. 9A, of. lanes 1 and  5) . Thus, HES-1 may negatively influence other factors that may be essential for transcription. In this regard, a region rich in prolines, a feature often observed in the domains involved in protein-protein interaction (Mermod et al. 1989) , may be interesting. Further studies should be done to address how HES-1 binding to the N box leads to transcriptional repression and which mammalian genes are regulated by HES-1 through the N box in vivo.
The mechanism of how HES-1 represses transcription through the E box is also an interesting question. Although HES-1 does not bind to the E box with a high affinity, it strongly antagonizes the function of HLH activators such as E47. Thus, like HES-3, Id, and HLH462, it is likely that nonfunctional heterodimer formation is responsible for negative regulation by HES-1, although it is possible that weak but direct interaction of HES-1 with the E box may also contribute to this negative regulation. These results indicate that HES-1 could repress transcription by two different mechanisms, depending on the sequences: repression by direct interaction with the N box and inhibition of other HLH activators from binding to the E box.
HES-1 negatively regulates the functions of MyoD and MASH1
HES-1 negatively regulates the functions of MyoD and MASH1 by inhibiting the MyoD/E47(E12) and MASH1/ E47(E12) complexes from binding to their target sequences. Our DNA-binding analysis shows that HES-1 does not inhibit the DNA-binding activity of the MyoD homodimer but almost completely inhibits that of E47. Thus, this strong interaction of HES-1 with E47 may lead to deprivation of the latter from the MyoD/E47 and MASH1/E47 complexes, resulting in the repression of MyoD and MASH1. However, other possibilities should also be considered. For example, excess HES-1 could form more multimeric oligomers such as the MyoD/ E47/HES-1 or MASH1/E47/HES-1 complexes. Weak interaction of HES-1 with the E box (Fig. 8B) could also lead to interference of the DNA binding of MyoD and MASH1.
HES-1 expression is developmentally controlled during myogenesis: Expression is at a high level in the embryonal muscle but at a low level in the adult muscle (Figs. 5A and 10D) . Furthermore, it represses the MyoDinduced myogenesis of 10T1/2 cells. Thus, it seems reasonable to hypothesize that HES-1 negatively regulates muscle differentiation in vivo. In this regard, the function of HES-1 is again similar to that of Id. However, the quantitative regulations of these two factors seem different in the course of muscle differentiation. When 10T1/2 cells are treated with serum-free medium (differentiation medium}, Id mRNA decreases dramatically {Weintraub et al. 1991), whereas HES-1 mRNA increases by severalfold (data not shown}. The latter then decreases in late myogenesis (Fig. 10D) . These results suggest that HES-1 and Id could take part in the regulation of muscle differentiation at different stages. However, we cannot exclude the possibility that HES-1 is not directly relevant to muscle differentiation but is involved in other functions in the developing muscle. Thus, whether the effects of HES-1 observed in the cell culture system reflect the in vivo situation should await further studies.
HES-1 also negatively regulates the function of MASH1, a mammalian homolog of Drosophila AS-C. In Drosophila, genetic analyses have shown that h has antagonizing activities against the proneural gene ac. Thus, our findings show interesting functional conservation between Drosophila h/ac and mammalian HES-1/ MASH1. However, little is yet known about the in vivo function of MASH 1, including its target genes, although the temporal and spatial expression pattern suggests the possible involvement of MASH1 in neural differentiation (Lo et al. 1991) . Therefore, in vivo function of HES-1 in relation to that of MASH1 awaits further analyses.
Our studies now provide the basis to investigate the intriguing questions discussed above, and further analysis of the HES genes will help in the understanding of the roles of HLH proteins in mammalian development.
Materials and methods
RNA isolation
Various tissues were obtained from 7-week-old Sprague-Dawley male rats and rat embryos of the indicated embryonic days. Poly(A) + RNA was prepared from total RNA by using oligo(dT) latex (Roche). The yield of poly(A) + RNA/total RNA was 3.2-5.7% depending on the type of tissues.
PCR experiments
After reverse transcription with oligo(dT) priming of poly(A) § RNA from whole embryo of day 17 or adult brain, the cDNA was submitted to 30-40 cycles of PCR under standard conditions (Lee et al. 1988; Saiki et al. 1988) , except that the annealing temperature was lowered to 45~ during the first five cycles. The fully degenerate primers corresponding to the following sequences were synthesized: RRAR(I/M)N and KAD(I/M)LE for the 5' and 3' primers, respectively. The third codon positions of fourfold degeneracy were substituted by inosine. BamHI and EcoRI sites were introduced at the 5' end of the 5' and 3' primers, respectively (the resulting primers were 25-met and 24-mer). Approximately 120-bp fragments were amplified, purified by electrophoresis, digested by EcoRI and BamHI, and subcloned into pBluescript SK(-). One dozen clones were randomly picked up and sequenced.
cDNA library screening
The construction of cDNA libraries was performed as described previously (Kageyama et al. 1991) . cDNAs were synthesized by oligo(dT) priming of poly(A) + RNAs of rat embryo {El7) and adult whole brain. Double-stranded cDNAs were then construtted, ligated to the EcoRI adaptor (New England Biolabs), and cloned into the EcoRI sites of the kgtl0 and kgtl 1 vectors. The SacI-KpnI fragment of the plasmid containing HES-1 or HES-3 PCR fragment was used as a probe. For HES-1, six positive clones were obtained by screening 5 x l0 s plaques of a Kgtl0 cDNA library of rat embryo CNS (El7), and the longest insert was subcloned into pBluescript SK{-) at the EcoRI site (pHES-1A). For HES-3, four positive clones were obtained from 1 X 10 6 plaques of an adult brain kgtl 1 cDNA library and were subcloned into the plasmid pHES-3A-pHES-3D.
Northern blot analysis
Five micrograms of poly(A) + RNA or 20 ~tg of total RNA was electrophoresed on a formamide/1.2% agarose gel and transferred to a nylon membrane filter (Biodyne, Pall Biosupports). The EcoRI{adaptor~-HincII fragment {646 bp)of pHES-1A and the EcoRI(adaptor~SmaI fragment (713 bp) of pHES-3A were labeled with ~2p by the random primer labeling method and used as a probe for HES-1 and HES-3, respectively. The filters were hybridized with the probes overnight at 42~ in 50% formamide, 5x SSC (20x SSC: 3M NaCI-O.3M sodium citrate), 5x Denhardt's reagent (Sx reagent: 0.1% Ficoll, 0.1% polyvinylpyrrolidone, 0.1% bovine serum albumin), 50 mM sodium phosphate buffer (pH 6.8), 0.1% SDS, and 100 ~g/ml of heatdenatured salmon sperm DNA. The filters were then washed in 0.1 x SSC and 0.1% SDS at 65~ and exposed to X-ray films for 30 hr.
RNase protection assay
RNase protection assays were performed as described previously (Tsuchida et al. 1990 ). The HincII fragment (330 bp} of pHES-1A was subcloned into the EcoRV site of pBluescript SK{ -), and a plasmid of the proper insert direction was selected. The EcoRI (adaptor)/EcoRV fragment (325 bp) of pHES-3A was subcloned into the EcoRI-EcoRV sites of the vector. The resulting plasmids were digested with SacI, and the antisense cRNAs were synthesized in the presence of [~-a2p] CTP by T7 RNA polymerase. As the synthesized probes contained the multiple cloning site portion of the vector at their 5' and 3' ends, their lengths were 443 and 430 bases for HES-1 and HES-3, respec-Cold Spring Harbor Laboratory Press on October 19, 2017 -Published by genesdev.cshlp.org Downloaded from tively. Total RNA (30 ~g) was hybridized overnight at 45~ in 80% formamide, 0.4 M NaC1, 40 rnM 1, 4-piperazinediethanesulfonate buffer (pH 6.4), and 1 mM EDTA and digested with RNase A and RNase T1. The RNase-resistant products were electrophoresed on a 7 M urea/5% polyacrylamide gel.
In situ hybridization
In situ hybridization experiments were performed as described previously (Masu et al. 1991 ) . ass-Labeled cRNAs corresponding to the EcoRI-SmaI fragment {723 bp) of pHES-1A and the EcoRI-PstI fragment {676 bp) of pHES-3A were synthesized in vitro. These probes were hybridized to 10-~m cryostat sections of various tissues.
DNA-binding analysis
The proteins were prepared as follows. The eDNA fragments of HES-1 [amino acid residues 3-2811, E47 (473-end), MyoD (53-end), were subcloned into either pGEMEX-1 {Promega) or pMNT T7 expression plasmids. The eDNA fragments used here contained a DNA-binding domain. pMNT was kindly provided by Dr. M. Nishizawa and Professor S. Nagata (Osaka Bioscience Institute, Osaka, Japan). JM109 (DE3) cells transformed by expression plasmids were grown and treated with 1 mM isopropyl-l-thio-B-D-galactopyranoside for 2 hr. The cells were collected and suspended in 0.02 volume of 30 mM Tris-HC1 (pH 7.51, 1 mM EDTA, and 20% [vol/vol) sucrose. The proteins were purified from the SDSpolyacrylamide gel, incubated in 6 M guanidine-HC1 for 20 min, and dialyzed against 0.1 M KC1/HM [20 mM HEPES at pH 7.9, 1 mM MgC12, 2 mM dithiothreitol, and 17% (vol/vol) glycerol] at 4~ for 8 hr.
The probe DNAs were prepared as follows. For the N box and E box (KE2) probes, the double-stranded oligonucleotide fragment, containing either two N boxes [CGGCACAAGGC and GCCACGAGTG) present in the promoter region of the E{spl) m8 gene or two repeats of KE2 sites {AGGCAGGTGGCC), was cloned into the EcoRI site of pBluescript II SK( -)-(Stratagene), and the XhoI-SacII fragment labeled at the XhoI site was isolated. For the CRE probe, the HinfI-PmaCI fragment of the PPT-A gene promoter labeled at the HinfI site was isolated (Kageyama et al. 1991) .
The DNase I footprinting reactions were carried out in a total volume of 50 ~1 containing 5 ng of the probe, as described previously (Dynan and Tjian 1983) .
The gel mobility-shift assay with the E(spl) N box or the MCK enhancer sequence was carried out as described previously (Benezra et al. 1990; Johnson et al. 1992; Tietze et al. 1992) . For N box binding, a double-stranded oligonucleotide (top strand, 5'-CTAGACGCCACGAGCCACAAGGATTG-3'; bottom strand, 5'-CTAGCAATCCTTGTGGCTCGTGGCGT-3') was labeled at both ends by filling in with Klenow enzyme in the presence of [~-s2p] dCTP and used as a probe. The mutations were introduced into both the CACGAG and CACAAG sequences, as indicated in Figure 8A .
CAT analysis and myogenic conversion assay
For the CAT reporter plasmid, the double-stranded oligonucleotide fragment containing either six repeats of the N boxes (three repeats of CCACGAGCCACAAGG for the wild type; three repeats of CCATGAGCCATAAGG for the mutated N box) or seven repeats of the E boxes (KE2 site) (AGGCAG-GTGGC) was cloned into the XhoI site (-273 relative to the transcription initiation site) of the [3-actin CAT plasmid.
For eukaryotic expression plasmids, full-length eDNA fragments of HES-1 and HES-3 were subcloned into the eukaryotic expression vector containing the CMV promoter pSV-CMV. Full-length E47 and MASH1 cDNAs were cloned from the human brain eDNA library and rat embryonal CNS library, respectively, and inserted into pSV-CMV. The E47 expression vector was also kindly provided by Dr. D. Baltimore {The Rockefeller University, New York). No difference was observed between the two clones. The MyoD expression vector driven by the [3-actin promoter and the CAT reporter plasmid containing the MCK enhancer and the thymidine kinase promoter were kindly provided by Drs. Y. Nabeshima and A. Fujisawa {Fujisawa-Sehara et al. 1990 ).
The CAT reporter {2 p.g) and the eukaryotic expression plasmids 18 ~tg each) were cotransfected into NIH-3T3 ceils using the calcium phosphate coprecipitation method. Two micrograms of pCDM8-B-gal, a [3-galactosidase gene expression vector driven by the CMV promoter, was also cotransfected to evaluate transfection efficiency. The total DNA amounts were adjusted to 22 p.g with pSV-CMV. CAT activities were determined, as described previously {Gorman et al. 1982). We used 1-deoxy [dichloroacetyl-l-14C] chloramphenicol {Amersham)as CAT substrate.
The CAT assays with MyoD and MASH1 and the myogenic conversion assay using 10T1/2 cells were carried out as described previously (Wright et al. 1989; Benezra et al. 1990; Johnson et al. 1992} .
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